ZLAB
Zai Lab Ltd
NASDAQ: ZLAB · HEALTHCARE · BIOTECHNOLOGY
$21.64
+4.29% today
Updated 2026-04-30
Market cap
$2.33B
P/E ratio
—
P/S ratio
5.07x
EPS (TTM)
$-1.60
Dividend yield
—
52W range
$16 – $44
Volume
0.8M
Zai Lab Ltd (ZLAB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-11.46M | $-32.16M | $-32.37M | $-97.54M | $-191.01M | $-216.06M | $-549.23M | $-367.64M | $-198.18M | $-214.87M | $-150.79M |
| Capital expenditures | $738470.00 | $2.23M | $9.12M | $10.12M | $15.24M | $10.67M | $18.95M | $24.98M | $8.49M | $61.52M | $8.10M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $2.70M | $4.93M | $9.93M | $12.23M | $20.29M | $24.83M | $40.71M | $61.30M | $79.63M | $70.65M | $65.60M |
| Free cash flow | $-12.20M | $-34.39M | $-41.48M | $-107.66M | $-206.25M | $-226.72M | $-568.18M | $-392.63M | $-206.67M | $-276.39M | $-158.89M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | $16.05M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — |